ColgatePalmolive (CL)
(Delayed Data from NYSE)
$96.49 USD
-0.11 (-0.11%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $96.50 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.49 USD
-0.11 (-0.11%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $96.50 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Zacks News
Colgate-Palmolive (CL) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Beats on Q3 Earnings and Sales, Ups View
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results benefit from robust pricing and a favorable mix, along with strength across its segments.
Colgate-Palmolive (CL) Just Reclaimed the 200-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
Colgate-Palmolive (CL) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Colgate-Palmolive (CL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Archer Daniels (ADM) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Archer Daniels' (ADM) first-quarter 2023 results are likely to reflect headwinds from higher costs and inflationary pressure. However, gains from solid demand are likely to aid the results.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Here's Why Investors Should Hold Colgate (CL) Stock for Now
by Zacks Equity Research
Pricing actions, revenue management initiatives, innovation, brand strength and digital growth position Colgate (CL) for growth amid higher costs and currency headwinds.
Zacks Industry Outlook Highlights The Procter & Gamble, Colgate-Palmolive, Henkel AG, Church & Dwight and The Clorox
by Zacks Equity Research
The Procter & Gamble, Colgate-Palmolive, Henkel AG, Church & Dwight and The Clorox are part of the Zacks Industry Outlook article.
5 Soaps & Cleaning Materials Stocks to Watch as Industry Catches Pace
by Rajani Lohia
The soap and cleaning materials industry looks poised for growth on robust demand, pricing initiatives, innovation, digital transformation and brand building, while elevated costs remain headwinds. Players like PG, CL, HENKY, CHD and CLX seem well-poised.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Colgate (CL) Earnings Meet Estimates in Q4, Sales Surpass
by Zacks Equity Research
Despite challenging macroeconomic conditions, gains from revenue growth management plans and continued momentum aid Colgate's (CL) Q4 results.
PCE Inflation Declined in December
by Zacks Equity Research
PCE Inflation Declined in December
PCE Melts Gently Overall; AXP, CVX, CL Post Q4 Results
by Mark Vickery
Year over year, headline PCE came in at +5.0%, a half-point lower than November's +5.5%.
Colgate-Palmolive (CL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Colgate-Palmolive (CL) Matches Q4 Earnings Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0% and 1.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Colgate (CL) is Well-Poised for Earnings Beat in Q4
by Zacks Equity Research
Colgate's (CL) Q4 results are expected to reflect gains from strong consumer demand, innovation, brand strength, and focus on premiumization and digital transformation.
Factors Likely to Influence Archer Daniels' (ADM) Q4 Earnings
by Zacks Equity Research
Archer Daniels (ADM) Q4 results are likely to reflect gains from solid demand, a strong Nutrition unit and efforts to expand its solutions portfolio. High costs and inflation are likely to have ailed.
Colgate-Palmolive (CL) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 0.63% and 0.81%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Time to Buy These Consumer Staples Stocks Before Earnings?
by Shaun Pruitt
As we progress through earnings season, investors may want to pay attention to the Consumer Staples sector as there are quite a few stocks that could beat earnings expectations.
Factors Likely to Affect Procter & Gamble's (PG) Q2 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results are likely to reflect the impacts of input cost inflation, higher freight, adverse product mix and increased packaging investments despite strong demand trends.
Will Colgate's (CL) Growth Strategies Aid Amid Cost Woes?
by Zacks Equity Research
Colgate (CL) is on track with its stringent pricing actions and accelerated revenue growth management plans. Higher raw material and logistic costs continue to hurt.
Colgate (CL) Q3 Earnings in Line, Higher Costs Hurt Outlook
by Zacks Equity Research
Gains from revenue growth management plans have led to pricing improvements across all regions, aiding Colgate???s (CL) Q3 results. Raw and packaging material, and logistic costs have hurt results.
Colgate-Palmolive (CL) Q3 Earnings Meet Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0% and 0.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?